Evidence map›Paper›PMID 25180240›Full record

ArticleThe Journal of infectious diseases2015

Absence of putative artemisinin resistance mutations among Plasmodium falciparum in Sub-Saharan Africa: a molecular epidemiologic study.

Steve M Taylor, Christian M Parobek, Derrick K DeConti, Kassoum Kayentao, Sheick Oumar Coulibaly, Brian M Greenwood, Harry Tagbor, John Williams, Kalifa Bojang, Fanta Njie and 16 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of infectious diseases, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 196 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
196citing papers in PubMed, 6 pooled it
37.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

196 citing papers in PubMed, 6 syntheses or guidelines pooled it, 292 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Trial
  9. Trial
  10. Changing Antimalarial Drug Sensitivities in Uganda.Antimicrobial agents and chemotherapy · 2017
    Trial
  11. Trial
  12. Trial
  13. Trial
  14. Trial
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Application of a new highly multiplexed amplicon sequencing tool to evaluatemedRxiv : the preprint server for health sciences · 2024
    Article

136 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

26 authors at 16 institutions in 12 countries.

Steve M TaylorDivision of Infectious Diseases, Department of Medicine Duke Global Health Institute, Duke University Medical Center, Durham Department of Epidemiology, Gillings School of Global Public Health.
Christian M ParobekCurriculum in Genetics and Molecular Biology.
Derrick K DeContiGraduate School of Biomedical Sciences.
Kassoum KayentaoDepartment of Epidemiology of Parasitic Diseases, Malaria Research and Training Center, Faculty of Medicine, Pharmacy, and Odontostomatology, University of Science, Techniques, and Technologies of Bamako, Mali Department of Clinical Sciences, Liverpool School of Tropical Medicine.
Sheick Oumar CoulibalyFaculty of Health Sciences, University of Ouagadougou, Burkina Faso.
Brian M GreenwoodFaculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, United Kingdom.
Harry TagborDepartment of Community Health, School of Medical Sciences, Kwame Nkrumah University of Science and Technology, Kumasi.
John WilliamsNavrongo Health Research Centre, Ghana Health Service, Navrongo.
Kalifa BojangMedical Research Council Laboratories, Banjul, Gambia.
Fanta NjieMedical Research Council Laboratories, Banjul, Gambia.
Meghna DesaiMalaria Branch, Division of Parasitic Diseases and Malaria, Center for Global Health, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia CDC-Kenya.
Simon KariukiKEMRI-CDC.
Julie GutmanMalaria Branch, Division of Parasitic Diseases and Malaria, Center for Global Health, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia.
Don P MathangaMalaria Alert Center, University of Malawi College of Medicine, Blantyre Department of Community Health, College of Medicine, Lilongwe, Malawi.
Andreas MårtenssonMalaria Research, Department of Medicine Solna Global Health, Department of Public Health Sciences, Karolinska Institutet, Stockholm, Sweden.
Billy NgasalaDepartment of Parasitology, Muhumbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.
Melissa D ConradDepartment of Medicine, University of California, San Francisco.
Philip J RosenthalDepartment of Medicine, University of California, San Francisco.
Antoinette K TshefuEcole de Sante Publique, Faculte de Medicine, University of Kinshasa, Democratic Republic of the Congo.
Ann M MoormannDepartment of Pediatrics.
John M VululeCenter for Global Health Research, KEMRI, Kisumu, Kenya.
Ogobara K DoumboDepartment of Epidemiology of Parasitic Diseases, Malaria Research and Training Center, Faculty of Medicine, Pharmacy, and Odontostomatology, University of Science, Techniques, and Technologies of Bamako, Mali.
Feiko O Ter KuileDepartment of Clinical Sciences, Liverpool School of Tropical Medicine Center for Global Health Research, KEMRI, Kisumu, Kenya.
Steven R MeshnickDepartment of Epidemiology, Gillings School of Global Public Health.
Jeffrey A BaileyDivision of Transfusion Medicine Program in Bioinformatics and Integrative Biology, University of Massachusetts School of Medicine, Worcester.
Jonathan J JulianoCurriculum in Genetics and Molecular Biology Divison of Infectious Diseases, School of Medicine, University of North Carolina, Chapel Hill.
Kenya Medical Research Institute · KEDivision of Parasitic Diseases and Malaria · USMRC Unit the Gambia · GMUniversity of Bamako · MLUniversity of California, San Francisco · USInstitute for Transfusion Medicine · USKarolinska Institutet · SEKwame Nkrumah University of Science and Technology · GHLondon School of Hygiene & Tropical Medicine · GBMuhimbili University of Health and Allied Sciences · TZNavrongo Health Research Centre · GHOffice of Infectious Diseases · USUniversité Joseph Ki-Zerbo · BFUniversity of Kinshasa · CDUniversity of Malawi · MWUniversity of North Carolina at Chapel Hill · US

Funding

Virology Research Program (Program 4)P30CA016086 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI David Darr · 1985 to 2026
$201.5M
Transmission ProjectU19AI089674 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Joaniter Immaculate Nankabirwa · 2010 to 2026
$29.3M
Resistance of Malaria Parasites to Artemisinin-Based TherapiesR01AI075045 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ROSENTHAL, PHILIP JON · 2009 to 2024
$8.4M
NRSA IN GENETICST32GM007092 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI SEKELSKY, JEFF J. · 1985 to 2019
$5.9M
Human copy number polymorphism and severe malariaR01AI099473 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI BAILEY, JEFFREY A. · 2012 to 2015
$2.3M
Within Host Selection of P. falciparum Variants by Artemisinin Combination TherapR01AI089819 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI JULIANO, JONATHAN J · 2010 to 2014
$1.9M
University of Massachusetts Center for Clinical and Translational ScienceKL2RR031981 · NCRR · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI SULLIVAN, JOHN LEWIS · 2010 to 2011
$1.2M
Molecular pathogenesis and genetic diversification of childhood falciparum malariK08AI100924 · NIAID · DUKE UNIVERSITY · PI TAYLOR, STEVE MYER · 2012 to 2016
$611k
Medical Research Council MC_UP_A900_1118NCI NIH HHS P30 CA016086NCRR NIH HHS KL2 RR031981NCRR NIH HHS KL2RR031981NIAID NIH HHS K08 AI100924NIAID NIH HHS K08AI100924NIAID NIH HHS R01 AI075045NIAID NIH HHS R01 AI089819NIAID NIH HHS R01AI089819NIAID NIH HHS R01 AI099473NIAID NIH HHS R56AI097909NIAID NIH HHS U19 AI089674NIAID NIH HHS U19AI089674NIGMS NIH HHS T32 GM007092NIGMS NIH HHS T32GM0088719
6 · The paper itself

Abstract

Plasmodium falciparum parasites that are resistant to artemisinins have been detected in Southeast Asia. Resistance is associated with several polymorphisms in the parasite's K13-propeller gene. The molecular epidemiology of these artemisinin resistance genotypes in African parasite populations is unknown. We developed an assay to quantify rare polymorphisms in parasite populations that uses a pooled deep-sequencing approach to score allele frequencies, validated it by evaluating mixtures of laboratory parasite strains, and then used it to screen P. falciparum parasites from >1100 African infections collected since 2002 from 14 sites across sub-Saharan Africa. We found no mutations in African parasite populations that are associated with artemisinin resistance in Southeast Asian parasites. However, we observed 15 coding mutations, including 12 novel mutations, and limited allele sharing between parasite populations, consistent with a large reservoir of naturally occurring K13-propeller variation. Although polymorphisms associated with artemisinin resistance in P. falciparum in Southeast Asia are not prevalent in sub-Saharan Africa, numerous K13-propeller coding polymorphisms circulate in Africa. Although their distributions do not support a widespread selective sweep for an artemisinin-resistant phenotype, the impact of these mutations on artemisinin susceptibility is unknown and will require further characterization. Rapid, scalable molecular surveillance offers a useful adjunct in tracking and containing artemisinin resistance.

Indexed as

MutationAdultAfrica South of the SaharaAntimalarialsArtemisininsChildChild, PreschoolFemaleGene FrequencyGenotypeHigh-Throughput Nucleotide SequencingHumansMalaria, FalciparumMaleMolecular EpidemiologyPlasmodium falciparumAntimalarialsartemisininArtemisininsartemisinin resistancedrug resistancefalciparum malariamolecular epidemiology

Identifiers

PMID25180240
PMCPMC4402372
OpenAlexW2119156545

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.